These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8991644

  • 21. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
    Chen MY, Lee KL, Hung CC.
    J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
    [Abstract] [Full Text] [Related]

  • 22. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity.
    Söderlund M, Brown CS, Cohen BJ, Hedman K.
    J Infect Dis; 1995 Mar; 171(3):710-3. PubMed ID: 7876624
    [Abstract] [Full Text] [Related]

  • 23. Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans.
    Zuffi E, Manaresi E, Gallinella G, Gentilomi GA, Venturoli S, Zerbini M, Musiani M.
    Viral Immunol; 2001 Mar; 14(2):151-8. PubMed ID: 11398810
    [Abstract] [Full Text] [Related]

  • 24. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
    Söderlund M, Brown CS, Spaan WJ, Hedman L, Hedman K.
    J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
    [Abstract] [Full Text] [Related]

  • 25. Design and production of a target-specific monoclonal antibody to parvovirus B19 capsid proteins.
    Kerr JR, O'Neill HJ, Deleys R, Wright C, Coyle PV.
    J Immunol Methods; 1995 Mar 13; 180(1):101-6. PubMed ID: 7534801
    [Abstract] [Full Text] [Related]

  • 26. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S.
    Arthritis Rheum; 2003 Jul 13; 48(7):1939-47. PubMed ID: 12847688
    [Abstract] [Full Text] [Related]

  • 27. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED, Rasksen CJ, Christensen J.
    J Med Virol; 2002 Jul 13; 67(3):375-83. PubMed ID: 12116031
    [Abstract] [Full Text] [Related]

  • 28. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
    Dobec M, Juchler A, Flaviano A, Kaeppeli F.
    Gynecol Obstet Invest; 2007 Jul 13; 63(1):53-4. PubMed ID: 16940737
    [Abstract] [Full Text] [Related]

  • 29. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.
    von Poblotzki A, Hemauer A, Gigler A, Puchhammer-Stöckl E, Heinz FX, Pont J, Laczika K, Wolf H, Modrow S.
    J Infect Dis; 1995 Nov 13; 172(5):1356-9. PubMed ID: 7594677
    [Abstract] [Full Text] [Related]

  • 30. [Seroepidemiology of human parvovirus B19 using recombinant VP1 + VP2 particle antigen].
    Matsunaga Y, Takeda N, Yamazaki S, Kamata K, Kurosawa D.
    Kansenshogaku Zasshi; 1995 Dec 13; 69(12):1371-5. PubMed ID: 8586889
    [Abstract] [Full Text] [Related]

  • 31. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays.
    Rice PS, Cohen BJ.
    Epidemiol Infect; 1996 Jun 13; 116(3):331-8. PubMed ID: 8666078
    [Abstract] [Full Text] [Related]

  • 32. Human parvovirus B19 and rheumatoid arthritis.
    Taylor HG, Borg AA, Dawes PT.
    Clin Rheumatol; 1992 Dec 13; 11(4):548-50. PubMed ID: 1486749
    [Abstract] [Full Text] [Related]

  • 33. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF, Claas EC, Sopaheluakan T, Kroes AC.
    J Clin Virol; 2005 Sep 13; 34(1):71-5. PubMed ID: 15985386
    [Abstract] [Full Text] [Related]

  • 34. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
    Erdman DD, Usher MJ, Tsou C, Caul EO, Gary GW, Kajigaya S, Young NS, Anderson LJ.
    J Med Virol; 1991 Oct 13; 35(2):110-5. PubMed ID: 1765775
    [Abstract] [Full Text] [Related]

  • 35. Human parvovirus B19-associated arthritis in children.
    Nocton JJ, Miller LC, Tucker LB, Schaller JG.
    J Pediatr; 1993 Feb 13; 122(2):186-90. PubMed ID: 8429430
    [Abstract] [Full Text] [Related]

  • 36. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L, Carta G, Barnabei R, Tomei E, Toro G, Moscarini M.
    Minerva Ginecol; 1995 Apr 13; 47(4):121-5. PubMed ID: 7644092
    [Abstract] [Full Text] [Related]

  • 37. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI, Enders M, Motz M.
    J Vet Med B Infect Dis Vet Public Health; 2005 Apr 13; 52(7-8):362-5. PubMed ID: 16316402
    [Abstract] [Full Text] [Related]

  • 38. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors.
    Manaresi E, Gallinella G, Morselli Labate AM, Zucchelli P, Zaccarelli D, Ambretti S, Delbarba S, Zerbini M, Musiani M.
    Epidemiol Infect; 2004 Oct 13; 132(5):857-62. PubMed ID: 15473148
    [Abstract] [Full Text] [Related]

  • 39. Parvovirus B19 antibodies in sera of patients with unexplained exanthemata from Belém, Pará, Brazil.
    de Freitas RB, de Miranda MF, Shirley J, Tudor R, Desselberger U, Linhares AC.
    Mem Inst Oswaldo Cruz; 1993 Oct 13; 88(3):497-9. PubMed ID: 8107612
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.